Kevin Alexander
@KMAlexanderMD
Physician-scientist, advanced heart failure and transplant cardiologist, amyloidosis specialist
ID:984309471617757184
12-04-2018 05:57:20
214 Tweets
705 Followers
450 Following
Are you a current cardiology fellow interested in HF as a career? Apply for visiting fellowship Stanford University‼️ Experience customized to your clinical/research interests.
Kiran Khush HFSA The ISHLT TCC Community of Practice (TCC COP) - AST
Details & how to apply on the Stanford University_HF website:
med.stanford.edu/heartfailure/h…
#ACC24 Day 2: Full house at the Cardiac Amyloidosis session!
Had the honor of presenting our work on sex differences in ATTR-CM risk prediction.
Key takeaway:
➡️ Efforts to scale ATTR-CM diagnosis should be mindful of sex differences!
Trejeeve (Tre) Martyn Ronald Witteles Kevin Alexander
Standing room only at the #Amyloidosis #CardioOnc moderated poster session at #ACC24 !
Excellent presentations moving the field forward!
Kevin Alexander Mathew Maurer Ronald Witteles Ahmad Masri
Welcome to another tweetorial on the newly reported epidemiology and outcomes in HF by BiykemBozkurt, Kevin Alexander Muthu Vaduganathan et. al. Journal of Cardiac Failure Robert Mentz, MD Anu Lala-Trindade with help from star resident Jenna Campbell Samir Mehta and edits from Alexander Hajduczok, MD 🇺🇦🙏
onlinejcf.com/article/S1071-…
2024 American Heart Association Bay Area research Roundtable kicking off w video & talks by key supporter of research in CV disease. Great turnout from Stanford Medicine Stanford CVI Stanford Department of Medicine faculty. Joseph C Wu, MD, PhD Eldrin Lewis Fatima Rodriguez Kevin Alexander Mintu Turakhia, MD MS AHA California
A lot more work is needed in V122I
Starting with identifying patients
Any Black patient >60 yo with heart failure and left ventricular hypertrophy requires active assessment. Dont stop at hypertension and/or kidney disease. Always explain LVH
#CardioTwitter
Grand Rounds tomorrow presented by Kevin Alexander
UC San Diego Cardiology Fellows UCSD Internal Medicine Residency UC San Diego Health Sciences @UCSDHealth
So great to work at a forward-facing institution with these remarkable humans. Let’s bring these therapies safely to the patients who need them. #SCICD Stanford Department of Medicine Eldrin Lewis Josh Knowles euan ashley Kevin Alexander Matthew Wheeler
#BCVS at #AHA23 continues with Ronglih Liao giving the George E. Brown Memorial Lecture on amyloidosis! Dr. Nikki Purcell Venkata Srikanth Garikipati Mingtao Zhao PhD @ NCH/OSU Sakthivel Sadayappan, PhD, MBA Jessica Pfleger Karch Lab Dr. Chi Fung Lee June Rhee Ron Vagnozzi Sean M Wu, MD PhD Joseph C Wu, MD, PhD AHA Science Kevin Alexander
🫀🎯 #PrecisionMedicine Session with an incredible line up this morning 🙌🏽 #AHA23 Neal Lakdawala Carolyn Ho Faraz Eric Adler Adam Helms Kevin Alexander #Heartfailure #cardiacamyloidosis #cardiomyopathy #CardioTwitter #AI AHA Science American Heart Association
Special talk about Precision Medicine in Amyloidosis diseases by Dr. Kevin Alexander Kevin Alexander
'Amyloid: Precision Medicine at its Best - From Diagnosis to Therapeutics' #AHA23 #CardioTwitter #Amyloid #ATTR AHA Science American Heart Association
Ready for a great session on the cutting edge of HFpEF. Come join! Jennifer Ho Marat Fudim, MD MHS Andrew J Sauer MD Ravi Patel Sanjiv J. Shah, MD Muthu Vaduganathan
Very proud to be invited to lecture at #AHA2023 about dual SGLT1/2 inhibition as a novel strategy for HFpEF!
Saturday 11/11 at 3.15-4.30pm to learn HFpEF therapies from amazing experts Muthu Vaduganathan @andrewjsauer Marat Fudim, MD MHS Sanjiv J. Shah, MD Kevin Alexander Jennifer Ho Ravi Patel
We have had an allstar lineup of visiting grand rounds speakers this past month: Ajay Kirtane, Michel Haissaguerre, & Vivek Y. Reddy
Today, Stanford’s very own Victoria Parikh, MD, Josh Knowles, & Kevin Alexander present a fantastic talk on gene editing for CV disease StanfordCVFellowship
Margaret Harris, PhD and Kevin Alexander impactful work demonstrating the learning gaps for clinicians when it comes to the dx and rx of cardiac amyloid in underserved pt populations #HFSA2023 #cardiacamyloid #implementationscience
🚨🚨🚨 Incredible resource for HF providers and patients‼️ Thanks to HFSA and Journal of Cardiac Failure. Shout out to Stanford Medicine's own Kiran Khush Kevin Alexander as co-authors. Sure to be the talk of #HFSA2023
@Stanford Stanford CVI Anu Lala-Trindade Robert Mentz, MD Eldrin Lewis
onlinejcf.com/article/S1071-…
(1/10) Today the long-awaited full results from the Phase 3 ATTRibute-CM trial were presented European Society of Cardiology #ESCCongress . We already knew the topline results from last month: Acoramidis made a (big) difference in outcomes! What more did we learn?🤔Let's dig deeper...